Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Carlo Bastianelli, Manuela Farris, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2017) Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism. Expert Review of Clinical Pharmacology 10:3, pages 315-326.
Read now
Read now
Cassiana Rosa Galvão Giribela, Fernanda Marciano Consolim-Colombo, Marcelo Gil Nisenbaum, Tercio Lemos de Moraes, Aricia Helena Galvão Giribela, Edmund Chada Baracat & Nilson Roberto de Melo. (2015) Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women. Gynecological Endocrinology 31:11, pages 912-915.
Read now
Read now
Iñaki Lete, Nathalie Chabbert-Buffet, Christian Jamin, Stefano Lello, Paloma Lobo, Rossella E. Nappi & Axelle Pintiaux. (2015) Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review. The European Journal of Contraception & Reproductive Health Care 20:5, pages 329-343.
Read now
Read now
Articles from other publishers (14)
Seyed Jalal Hashemi, Rozhan Khezri, Nader Saki, Nahal Nasehi, Seyed Ahmad Hosseini, Mahmood Harizi & Zahra Rahimi. (2023) Association between oral contraceptives with lipid profile: results from Hoveyzeh cohort study (HCS). BMC Women's Health 23:1.
Crossref
Crossref
Pedro-Antonio Regidor, Anna Mueller & Manuela Mayr. (2023) Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen. Women's Health 19, pages 174550572211473.
Crossref
Crossref
Ilaria Campesi, Andrea Montella, Giovanni Sotgiu, Laura Saderi, Giancarlo Tonolo, Giuseppe Seghieri & Flavia Franconi. (2022) Smoking and combined oral contraceptives should be considered as an independent variable in sex and gender-oriented studies. Toxicology and Applied Pharmacology 457, pages 116321.
Crossref
Crossref
Katarzyna Kowalska, Milena Ściskalska, Anna Bizoń, Mariola Śliwińska-Mossoń & Halina Milnerowicz. (2018) Influence of oral contraceptives on lipid profile and paraoxonase and commonly hepatic enzymes activities. Journal of Clinical Laboratory Analysis 32:1, pages e22194.
Crossref
Crossref
Jessica W Kiley & Leanne R Griffin. (2015) Contraceptive care after gestational diabetes: considerations for clinical practice. Diabetes Management 5:6, pages 457-472.
Crossref
Crossref
Angelo Cagnacci, Ilaria Piacenti, Renata Zanin, Anjeza Xholli & Alessandra Tirelli. (2014) Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women. European Journal of Obstetrics & Gynecology and Reproductive Biology 178, pages 48-50.
Crossref
Crossref
Shahnaz TorkzahraniAfrooz HeidariZohreh Mostafavi-pourMajid AhmadiFatemeh Zal. (2014) Amelioration of lipid abnormalities by vitamin therapy in women using oral contraceptives. Clinical and Experimental Reproductive Medicine 41:1, pages 15.
Crossref
Crossref
José A. Guerra, Francisco López-Muñoz & Cecilio Álamo. (2013) Progestins in Combined Contraceptives. Journal of Experimental & Clinical Medicine 5:2, pages 51-55.
Crossref
Crossref
Regine Sitruk-Ware & Anita Nath. (2013) Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Practice & Research Clinical Endocrinology & Metabolism 27:1, pages 13-24.
Crossref
Crossref
Regine Sitruk-Ware & Anita Nath. (2011) Metabolic effects of contraceptive steroids. Reviews in Endocrine and Metabolic Disorders 12:2, pages 63-75.
Crossref
Crossref
Regine Sitruk-Ware & Anita Nath. (2010) The use of newer progestins for contraception. Contraception 82:5, pages 410-417.
Crossref
Crossref
Rogério Bonassi Machado, Nilson Roberto de Melo, Hugo MaiaJr.Jr. & Achilles Machado Cruz. (2010) Effect of a continuous regimen of contraceptive combination of ethinylestradiol and drospirenone on lipid, carbohydrate and coagulation profiles. Contraception 81:2, pages 102-106.
Crossref
Crossref
Nevin Sağsöz, Zerrin Orbak, Volkan Noyan, Aykan Yücel, Banu Uçar & Leyla Yıldız. (2009) The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome. Fertility and Sterility 92:2, pages 660-666.
Crossref
Crossref
Recep Yildizhan, Begum Yildizhan, Ertan Adali, Pinar Yoruk, Fatih Birol & Necdet Suer. (2009) Effects of two combined oral contraceptives containing ethinyl estradiol 30 μg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure. Archives of Gynecology and Obstetrics 280:2, pages 255-261.
Crossref
Crossref